LPCN
Lipocine Inc.
NASDAQ · USHealthcareBiotechnology
$2.15-3.59%
Price as of Jul 20, 2026
LPCN valuation
Lipocine Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 88.63x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.78x
- Price / sales
- 8.85x
- Price / cash flow
- -1.76x
Enterprise value
- Enterprise value
- -$7.0M
- EV / sales
- -3.50x
- EV / EBITDA
- 0.62x
- EV / EBIT
- 0.58x
- Market cap
- $17.7M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.